Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Chunquan Sheng, Guoqiang Dong, Zhenyuan Miao, et al.
Chemical Society Reviews (2015) Vol. 44, Iss. 22, pp. 8238-8259
Closed Access | Times Cited: 148

Showing 26-50 of 148 citing articles:

The Potential of the Cyclotide Scaffold for Drug Development
Julio A. Camarero, Maria Jose Campbell
Biomedicines (2019) Vol. 7, Iss. 2, pp. 31-31
Open Access | Times Cited: 53
Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
Chung‐Hang Leung, Jia-Tong Zhang, Guan‐Jun Yang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4445-4445
Open Access | Times Cited: 47
Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)
Hai-Shan Zhou, Yan Wang, Qidong You, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 3, pp. 209-225
Closed Access | Times Cited: 42
Targeting Protein–Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches
Alessandra Monti, Luigi Vitagliano, Andrea Caporale, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7842-7842
Open Access | Times Cited: 14
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
Yuqing Lu, Yuewen Yang, Guanghao Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3360-3382
Open Access | Times Cited: 14
The future of therapeutic options for hereditary angioedema
Tukisa Smith, Marc A. Riedl
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 4, pp. 380-390
Closed Access | Times Cited: 5
Emerging roles of A-kinase anchoring proteins in cardiovascular pathophysiology
Dario Diviani, Erica Reggi, Miroslav Arambasic, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2015) Vol. 1863, Iss. 7, pp. 1926-1936
Open Access | Times Cited: 48
Targeting Unoccupied Surfaces on Protein–Protein Interfaces
David Rooklin, Ashley E. Modell, Haotian Li, et al.
Journal of the American Chemical Society (2017) Vol. 139, Iss. 44, pp. 15560-15563
Open Access | Times Cited: 46
Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators
Lucía Pérez-Regidor, Malik Zarioh, Laura G. Ortega, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 9, pp. 1508-1508
Open Access | Times Cited: 44
Side-Chain Conformational Preferences Govern Protein–Protein Interactions
Andrew M. Watkins, Richard Bonneau, Paramjit S. Arora
Journal of the American Chemical Society (2016) Vol. 138, Iss. 33, pp. 10386-10389
Open Access | Times Cited: 42
In silico identification of essential proteins in Corynebacterium pseudotuberculosis based on protein-protein interaction networks
Edson Luiz Folador, Paulo Vinícius Sanches Daltro de Carvalho, Wanderson Marques da Silva, et al.
BMC Systems Biology (2016) Vol. 10, Iss. 1
Open Access | Times Cited: 39
Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases
Qi Li, Shuaishuai Xing, Ying Chen, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111862-111862
Closed Access | Times Cited: 39
Scanning Protein Surfaces with DNA‐Encoded Libraries
Verena B. K. Kunig, Marco Potowski, Mateja Klika Škopić, et al.
ChemMedChem (2020) Vol. 16, Iss. 7, pp. 1048-1062
Open Access | Times Cited: 39
Fr-PPIChem: An Academic Compound Library Dedicated to Protein–Protein Interactions
Nicolas Bosc, Christophe Müller, Laurent Hoffer, et al.
ACS Chemical Biology (2020) Vol. 15, Iss. 6, pp. 1566-1574
Open Access | Times Cited: 38
Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)
Yuran Qiu, Xinyi Li, Xinheng He, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112764-112764
Closed Access | Times Cited: 35
Modulators of protein–protein interactions as antimicrobial agents
Rashi Kahan, Dennis J. Worm, Guilherme V. Castro, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 2, pp. 387-409
Open Access | Times Cited: 28
Waste-Minimized Continuous-Flow Synthesis of Oxindoles Exploiting a Polymer-Supported N Heterocyclic Palladium Carbene Complex in a CPME/Water Azeotrope
Nihad Salameh, Francesco Ferlin, Federica Valentini, et al.
ACS Sustainable Chemistry & Engineering (2022) Vol. 10, Iss. 11, pp. 3766-3776
Open Access | Times Cited: 21
Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
Binu Jacob, Alicia Vogelaar, Enrique Cadenas, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6430-6430
Open Access | Times Cited: 20
Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery
Daniela Trisciuzzi, Bruno O. Villoutreix, Lydia Siragusa, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 7, pp. 737-752
Closed Access | Times Cited: 13
Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 12
A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein–protein interactions identifies a novel putative Mdm2-binding site in p53
Jin Huei Wong, Mohammad Alfatah, Mei Fang Sin, et al.
BMC Biology (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Targeting Helicobacter pylori urease activity and maturation: In-cell high-throughput approach for drug discovery
Cinzia Tarsia, Alberto Danielli, Francesca Florini, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2018) Vol. 1862, Iss. 10, pp. 2245-2253
Open Access | Times Cited: 33
Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein–protein interactions
Dipankar Chaudhuri, Teshome Leta Aboye, Julio A. Camarero
Biochemical Journal (2019) Vol. 476, Iss. 1, pp. 67-83
Open Access | Times Cited: 32
Pyrrolopyrimidine vs Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase
Alejandro Revuelto, Marta Ruiz‐Santaquiteria, Héctor de Lucio, et al.
ACS Infectious Diseases (2019) Vol. 5, Iss. 6, pp. 873-891
Closed Access | Times Cited: 32
Hot Spot Analysis of YAP-TEAD Protein-Protein Interaction Using the Fragment Molecular Orbital Method and Its Application for Inhibitor Discovery
Jongwan Kim, Hocheol Lim, Sungho Moon, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4246-4246
Open Access | Times Cited: 26

Scroll to top